JORNAY PM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Jornay Pm, and what generic alternatives are available?
Jornay Pm is a drug marketed by Ironshore Pharms and is included in one NDA. There are sixteen patents protecting this drug.
This drug has thirty-nine patent family members in fourteen countries.
The generic ingredient in JORNAY PM is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Jornay Pm
A generic version of JORNAY PM was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for JORNAY PM?
- What are the global sales for JORNAY PM?
- What is Average Wholesale Price for JORNAY PM?
Summary for JORNAY PM
International Patents: | 39 |
US Patents: | 16 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Patent Applications: | 3,514 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for JORNAY PM |
What excipients (inactive ingredients) are in JORNAY PM? | JORNAY PM excipients list |
DailyMed Link: | JORNAY PM at DailyMed |
![JORNAY PM drug patent expirations Drug patent expirations by year for JORNAY PM](/p/graph/s/t/JORNAY_PM-patent-expirations.png)
![Drug Prices for JORNAY PM](/p/graph/drug-price/JORNAY+PM.png)
Pharmacology for JORNAY PM
Drug Class | Central Nervous System Stimulant |
Physiological Effect | Central Nervous System Stimulation |
US Patents and Regulatory Information for JORNAY PM
JORNAY PM is protected by sixteen US patents.
Patents protecting JORNAY PM
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Methods of treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Methods for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Methods and compositions for treatment of attention deficit disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Methods for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compositions for treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Methods of treatment of attention deficit hyperactivity disorder
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-005 | Aug 8, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-003 | Aug 8, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-002 | Aug 8, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for JORNAY PM
See the table below for patents covering JORNAY PM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 6043785 | ⤷ Sign Up | |
Japan | 2024019726 | 注意欠陥障害の処置のための方法および組成物 | ⤷ Sign Up |
China | 110151731 | 用于治疗注意力缺陷障碍的方法和组合物 (METHODS AND COMPOSITIONS FOR TREATMENT OF ATTENTION DEFICIT DISORDER) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |